Corona Remedies Board recommended a final dividend of ₹10 per share for FY 2025-26, subject to shareholder approval at the AGM.
The company will deduct TDS on dividend payments as per Income Tax Act, 2025, with rates varying by shareholder residency status and documentation.
Shareholders must submit required tax exemption documents and declarations to the RTA by June 19, 2026, to determine applicable TDS rates.
Dividend will be paid electronically to shareholders on record as of June 19, 2026, based on bank details registered with depository participants.